Chromadex Corp
NASDAQ:CDXC
Chromadex Corp
Accounts Payable
Chromadex Corp
Accounts Payable Peer Comparison
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Chromadex Corp
NASDAQ:CDXC
|
Accounts Payable
$7.9m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
15%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Accounts Payable
$2.6B
|
CAGR 3-Years
6%
|
CAGR 5-Years
12%
|
CAGR 10-Years
12%
|
|
Danaher Corp
NYSE:DHR
|
Accounts Payable
$1.7B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Accounts Payable
$189.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
2%
|
CAGR 10-Years
5%
|
|
Agilent Technologies Inc
NYSE:A
|
Accounts Payable
$488m
|
CAGR 3-Years
7%
|
CAGR 5-Years
9%
|
CAGR 10-Years
1%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Accounts Payable
$3.6B
|
CAGR 3-Years
8%
|
CAGR 5-Years
52%
|
CAGR 10-Years
15%
|
See Also
What is Chromadex Corp's Accounts Payable?
Accounts Payable
7.9m
USD
Based on the financial report for Mar 31, 2024, Chromadex Corp's Accounts Payable amounts to 7.9m USD.
What is Chromadex Corp's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
15%
Over the last year, the Accounts Payable growth was -12%. The average annual Accounts Payable growth rates for Chromadex Corp have been -12% over the past three years , -4% over the past five years , and 15% over the past ten years .